| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Feb 2025 | 23 Jan 2025 |
| NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve The Unaudited Financial Results of the Company For The Quarter And Nine Months Ended December 31 2024 Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2024 (As Per BSE Announcement Dated on 10/02/2025) | ||
| Board Meeting | 6 Nov 2024 | 17 Oct 2024 |
| NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2024 Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024 (As Per BSE Announcement Dated on 06.11.2024) | ||
| Board Meeting | 1 Aug 2024 | 17 Jul 2024 |
| NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve the unaudited financial results of the Company for the Quarter ended June 30 2024 Unaudited Financial results for quarter ended June 30, 2024 (As per BSE Announcement Dated on 01/08/2024) | ||
| Board Meeting | 10 May 2024 | 23 Apr 2024 |
| NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2024 and; to recommend final dividend if any for the financial year ended March 31 2024 Recommendation of final dividend for the financial year 2023-24 Audited Financial Results and recommendation of final dividend for financial year 2023-2024 Recommendation of final dividend for the financial year 2023-24 Book closure for dividend and Annual General Meeting scheduled on Wednesday, July 31, 2024 Re-appointment of Statutory Auditors (As Per BSE Announcement dated on 10.05.2024) | ||
The transaction takes place against the backdrop of a more than 9% reduction in the stock's value during the previous week.
However, it is unclear whether the Hyderabad-based company will be Cobenfy's exclusive supplier.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
